TG Therapeutics Q3 EPS $0.35 Beats $0.34 Estimate, Sales $259.936M Beat $245.475M Estimate
Benzinga Newsdesk 1 hour ago
NewsEarningsEarnings Beats
TG Therapeutics (NASDAQ:TGTX) reported quarterly earnings of $0.35 per share which beat the analyst consensus estimate of $0.34 by 2.94 percent. This is a 85.6 percent decrease over earnings of $2.43 per share from the
TG Therapeutics (NASDAQ:TGTX) reported quarterly earnings of $0.35 per share which beat the analyst consensus estimate of $0.34 by 2.94 percent. This is a 85.6 percent decrease over earnings of $2.43 per share from the same period last year. The company reported quarterly sales of $259.936 million which beat the analyst consensus estimate of $245.475 million by 5.89 percent. This is a 60.74 percent increase over sales of $161.709 million the same period last year.